The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Turovinina E.F.

Tyumen State Medical University

Loginova N.V.

Department of Health of the Tyumen Region

Peretyagina N.R.

Tyumen State Medical University

Kleshchevnikova T.M.

City Polyclinic No. 12

Elfimova I.V.

Tyumen State Medical University

Evaluation of clinical manifestations of sarcopenia in elderly people in the Tyumen region

Authors:

Turovinina E.F., Loginova N.V., Peretyagina N.R., Kleshchevnikova T.M., Elfimova I.V.

More about the authors

Journal: Russian Journal of Preventive Medicine. 2024;27(5): 69‑74

Read: 2335 times


To cite this article:

Turovinina EF, Loginova NV, Peretyagina NR, Kleshchevnikova TM, Elfimova IV. Evaluation of clinical manifestations of sarcopenia in elderly people in the Tyumen region. Russian Journal of Preventive Medicine. 2024;27(5):69‑74. (In Russ.)
https://doi.org/10.17116/profmed20242705169

Recommended articles:
The role of protein in the elde­rly patients nutrition. Russian Journal of Preventive Medi­cine. 2026;(2):90-96
Gender and age-specific aspe­cts of mental health in children and adolescents. S.S. Korsakov Journal of Neurology and Psychiatry. 2026;(2):109-115

References:

  1. Rosenberg I.H. Sarcopenia: Origins and clinical relevance. The Journal of Nutrition. 1997;127(5):990S-991S. https://doi.org/10.1093/jn/127.5.990S
  2. Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2, Sarcopenia: revised European consensus on definition and diagnosis, Age and Ageing. 2019;48(1):16-31.  https://doi.org/10.1093/ageing/afy169
  3. Nair KS. Age-related changes in muscle. Mayo Clinic Proceedings. 2000; 75:14-18.  https://doi.org/10.1016/S0025-6196(19)30636-6
  4. Tkacheva ON, Kotovskaya YuV, Runikhina NK, et al. Clinical guidelines on frailty. Rossijskij zhurnal geriatricheskoj mediciny. 2020;(1):11-46. (In Russ.). https://doi.org/10.37586/2686-8636-1-2020-11-46
  5. Beaudart C, Biver E, Reginster J-Y, et al. Development of a self-administrated quality of life questionnaire for sarcopenia in elderly subjects: the SarQoL. Age Ageing. 2015;44(6):960-966.  https://doi.org/10.1093/ageing/afv133
  6. Safonova YuA, Lesnyak OM, Baranova IA, et al. Russian translation and validation of SARQOL®, a quality of life questionnaire for patients with sarcopenia. Nauchno-prakticheskaya revmatologiya. 2019;57(1):38-45. (In Russ.).
  7. Turovinina EF, Loginova NV, Kleshchevnikova TM, et al. The first results of the assessment of the prevalence of sarcopenia in the elderly in Tyumen. Meditsinskaya nauka i obrazovanie Urala. 2023;24(1):54-58. (In Russ.). https://doi.org/10.36361/18148999_2023_24_1_54
  8. Bogat SV. The prevalence of sarcopenia in patients of older age groups. Gerontologiya. 2014;3(2):305-310. (In Russ.).
  9. Safonova YuA, Zotkin EG, Toroptsova NV. Quality of life and fatigue in elderly patients with sarcopenia. Sovremennaja revmatologija. 2021;15(6):41-47. (In Russ.). https://doi.org/10.14412/1996-7012-2021-6-41-47
  10. Bulgakova SV, Treneva EV, Zakharova NO, et al. Sarcopenia: a multicomponent strategy for diagnosis and therapy (literature review). Uspekhi gerontologii. 2019;32(3):405-414. (In Russ).
  11. Hwang J, Park S. Sex Differences of Sarcopenia in an Elderly Asian Population: The Prevalence and Risk Factors. International Journal of Environmental Research and Public Health. 2022;19(19):11980. https://doi.org/10.3390/ijerph191911980
  12. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: report of the European working group on Sarcopenia in older people. Age Ageing. 2010;39(4):412-423.  https://doi.org/10.1093/ageing/afq034
  13. Wang C, Bai LJ. Sarcopenia in the elderly: Basic and clinical issues. Geriatrics and Gerontology International. 2012;12:388-396.  https://doi.org/10.1111/j.1447-0594.2012.00851.x
  14. Golovanova ED, Titova NE, Afanasenkova TE, et al. The prevalence and features of therapy of geriatric syndromes in patients of older age groups: a clinical and epidemiological study. Uspekhi gerontologii. 2020;33(2):331-338. (In Russ.). https://doi.org/10.17816/RFD2017421-28
  15. Peterson SJ, Mozer M. Differentiating Sarcopenia and Cachexia Among Patients With Cancer. Nutrition in Clinical Practice. 2017;32(1):30-39.  https://doi.org/10.1177/0884533616680354
  16. Dennison E, Sayer AA, Cooper C. Epidemiology of sarcopenia and insight into possible therapeutic targets. Nature Reviews. Rheumatology. 2017;13:340-347.  https://doi.org/10.1038/nrrheum.2017.60
  17. Pacifico J, Geerlings MA, Reijnierse EM, et al. Prevalence of sarcopenia as a comorbid disease: A systematic review and meta-analysis. Experimental Gerontology. 2019;131:110801. https://doi.org/10.1016/j.exger.2019.110801
  18. Yamada M, Nishiguchi S, Fukutani N, et al. Prevalence of Sarcopenia in Community-Dwelling Japanese Older Adults. Journal of the American Medical Directors Association. 2013;14:911-915.  https://doi.org/10.1016/j.jamda.2013.08.015
  19. Grigor’eva II, Raskina TA, Letaeva MV, et al. Sarcopenia: features of pathogenesis and diagnosis. Fundamental’naya i klinicheskaya meditsina. 2019;4(4): 105-116. (In Russ.). https://doi.org/10.23946/2500-0764-2019-4-4-105-116
  20. Sheptulina AF, Dzhioeva ON, Drapkina OM. Sarcopenia and non-alcoholic fatty liver disease: shared pathogenesis mechanisms as possible targets of therapy and prevention. Russian Journal of Preventive Medicine. 2021;24(4): 57-62. (In Russ.). https://doi.org/10.17116/profmed20212404157
  21. Pleshchev IE, Nikolenko VN, Achkasov EE, Shkrebko AN. Constitutional and anatomical features of elderly men with sarcopenia. Morfologicheskie vedomosti. 2023;31(1):714. (In Russ.). https://doi.org/10.20340/mv-mn.2023.31(1).714
  22. Kitamura A, Seino S, Abe T, et al. Sarcopenia: prevalence, associated factors, and the risk of mortality and disability in Japanese older adults. Journal of Cachexia Sarcopenia of Muscle. 2021;12(1):30-38.  https://doi.org/10.1002/jcsm12651

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.